(Q42468205)

1 November 2017

title

Tumor necrosis factor reduces cAMP production in rat microglia (English)

1 reference

1 November 2017

0 references

Mario Patrizio

1

1 reference

1 November 2017

publication date

1 November 2004

1 reference

1 November 2017

1 reference

1 November 2017

volume

48

1 reference

1 November 2017

issue

3

1 reference

1 November 2017

page(s)

241-249

1 reference

Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

Tumor necrosis factor-alpha expression in ischemic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

Heterotypic and homotypic cellular interactions influencing the growth and differentiation of bipotential oligodendrocyte-type-2 astrocyte progenitors in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit CBP-NF-kappaB interaction in activated microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Expression of the p75 TNF receptor is linked to TNF-induced NFkappaB translocation and oxyradical neutralization in glial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

CREB-binding protein/p300 are transcriptional coactivators of p65

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Elevation of tumor necrosis factor in head injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Differential regulation of cytokine-induced major histocompatibility complex class II expression and nitric oxide release in rat microglia and astrocytes by effectors of tyrosine kinase, protein kinase C, and cAMP

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

TNF-alpha increases transcription of Galpha(i-2) in human airway smooth muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Human immunodeficiency virus coat protein gp120 inhibits the beta-adrenergic regulation of astroglial and microglial functions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Up-regulation of cyclooxygenase-2 expression in cultured microglia by prostaglandin E2, cyclic AMP and non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Interferon-gamma and lipopolysaccharide reduce cAMP responses in cultured glial cells: reversal by a type IV phosphodiesterase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Selective enhancement by serum factors of cyclic AMP accumulation in rat microglial cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Opposite regulation of adenylyl cyclase by protein kinase C in astrocyte and microglia cultures.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

beta-adrenergic receptor stimulation selectively inhibits IL-12p40 release in microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

The presence of tumour necrosis factor in CSF and plasma after severe head injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Involvement of inflammatory cytokines in central nervous system injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Production of tumor necrosis factor in spinal cord following traumatic injury in rats

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20074

7 January 2021

Identifiers

DOI

10.1002/GLIA.20074

1 reference

1 November 2017

1 reference